Flip-flop phenomenon on dual SSTR PET and amino acid PET in a case of recurrent meningioma with malignant transformation

Amino acid PET is used for glioma imaging but has no established role in meningioma [1,2].We present a "flipflop" constellation on SSTR and amino acid PET in meningioma that enabled to detect unrecognized malignant tumor tissue.A 65-year-old patient in continuous clinical followup presented with a new contrast-enhancing lesion on MRI in the left cerebral peduncle (red arrows), 5 years after radiotherapy of a left temporal suspected low-grade meningioma, and 1 year after its resection (revealing atypical meningioma CNS WHO grade 2).The patient received ongoing everolimus/octreotide for dural tumor remnants (green arrows).MRI findings were suggestive of reactive changes but could not exclude vital tumor.SSTR-targeted PET/CT with 187 MBq [ 18 F]SiTATE showed markedly increased SSTRexpression at the known residue, whereas the adjacent new lesion only showed low tracer uptake, suggesting radiation necrosis [3].Due to uncommon late-onset after radiotherapy, additional amino acid PET with 173 MBq [ 18 F]FET was performed.In contrast to SSTR-PET, [ 18 F]FET-PET displayed only minor uptake in the known meningioma residue; and while the time-activity curves were continuously increasing in the dynamic analysis, the new lesion showed markedly increased [ 18 F]FET uptake, typical for malignant tumor tissue.Taken together, the findings were suggestive for meningioma recurrence with signs of dedifferentiation and malignant transformation.Stereotactic biopsy revealed malignant tumor tissue but was inconclusive regarding the tumor type.Eventually, surgical resection of the new lesion revealed malignant meningioma, now classified as CNS WHO grade 3, including homozygote CDKN2A/B deletion in the DNA-methylation profile [4], which was not present in the initial CNS WHO grade 2 tumor.Additional amino acid PET imaging in meningioma may help to identify

Authors

Institutions

Publication Details

Journal
European Journal of Nuclear Medicine and Molecular Imaging
Published
2024-11-26
DOI
https://doi.org/10.1007/s00259-024-06998-y
Citations
3
Primary Topic
Meningioma and schwannoma management
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Flip-flop phenomenon on dual SSTR PET and amino acid PET in a case of recurrent meningioma with malignant transformation

J. C. Tonn, Robert Forbrig, Patrick N. Harter, Louisa von Baumgarten et al.
3 citations
European Journal of Nuclear Medicine and Molecular Imaging
Meningioma and schwannoma management
1.16
article

Flip-flop phenomenon on dual SSTR PET and amino acid PET in a case of recurrent meningioma with malignant transformation

J. C. Tonn, Robert Forbrig, Patrick N. Harter, Louisa von Baumgarten, Christian Schichor, Nathalie L. Albert, Matthias Brendel, Adrien Holzgreve, Maximilian Niyazi, Stefanie Quach, Niklas Thon
article en
3 citations

Abstract

Amino acid PET is used for glioma imaging but has no established role in meningioma [1,2].We present a "flipflop" constellation on SSTR and amino acid PET in meningioma that enabled to detect unrecognized malignant tumor tissue.A 65-year-old patient in continuous clinical followup presented with a new contrast-enhancing lesion on MRI in the left cerebral peduncle (red arrows), 5 years after radiotherapy of a left temporal suspected low-grade meningioma, and 1 year after its resection (revealing atypical meningioma CNS WHO grade 2).The patient received ongoing everolimus/octreotide for dural tumor remnants (green arrows).MRI findings were suggestive of reactive changes but could not exclude vital tumor.SSTR-targeted PET/CT with 187 MBq [ 18 F]SiTATE showed markedly increased SSTRexpression at the known residue, whereas the adjacent new lesion only showed low tracer uptake, suggesting radiation necrosis [3].Due to uncommon late-onset after radiotherapy, additional amino acid PET with 173 MBq [ 18 F]FET was performed.In contrast to SSTR-PET, [ 18 F]FET-PET displayed only minor uptake in the known meningioma residue; and while the time-activity curves were continuously increasing in the dynamic analysis, the new lesion showed markedly increased [ 18 F]FET uptake, typical for malignant tumor tissue.Taken together, the findings were suggestive for meningioma recurrence with signs of dedifferentiation and malignant transformation.Stereotactic biopsy revealed malignant tumor tissue but was inconclusive regarding the tumor type.Eventually, surgical resection of the new lesion revealed malignant meningioma, now classified as CNS WHO grade 3, including homozygote CDKN2A/B deletion in the DNA-methylation profile [4], which was not present in the initial CNS WHO grade 2 tumor.Additional amino acid PET imaging in meningioma may help to identify

European Journal of Nuclear Medicine and Molecular ImagingVol. 52(6)
German Cancer Research Center (DE), German Center for Neurodegenerative Diseases (DE), LMU Klinikum (DE), Munich Cluster for Systems Neurology (DE), University Children's Hospital Tübingen (DE), Bernstein Center for Computational Neuroscience Tübingen (DE), Molecular Theranostics (United States) (US), Deutsches Konsortium für Translationale Krebsforschung (DE), Ludwig-Maximilians-Universität München (DE)
Zero hunger
Openalex Percentile: Top 19%
Meningioma and schwannoma management
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.